These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 27316483

  • 21. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis.
    Erbay AR, Turhan H, Yasar AS, Bicer A, Senen K, Sasmaz H, Sabah I, Yetkin E.
    Int J Cardiol; 2005 Jun 22; 102(1):33-7. PubMed ID: 15939096
    [Abstract] [Full Text] [Related]

  • 22. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 23. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 24. [Short-term course under beta blockers of clinical and echocardiographic parameters in mitral stenosis in sinus rhythm].
    Kane A, Djamadar SY, Affangla A, Diop IB, Sarr M, Ba SA, Diouf SM.
    Ann Cardiol Angeiol (Paris); 2000 Oct 27; 49(7):397-402. PubMed ID: 12555492
    [Abstract] [Full Text] [Related]

  • 25. Peak oxygen uptake during exercise in mitral stenosis with sinus rhythm or atrial fibrillation: lack of correlation with valve area. A study in 70 patients.
    Cohen-Solal A, Aupetit JF, Dahan M, Baleynaud S, Slama M, Gourgon R.
    Eur Heart J; 1994 Jan 27; 15(1):37-44. PubMed ID: 8174582
    [Abstract] [Full Text] [Related]

  • 26. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 27; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 27. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Hidalgo FJ, Anguita M, Castillo JC, Rodríguez S, Pardo L, Durán E, Sánchez JJ, Ferreiro C, Pan M, Mesa D, Delgado M, Ruiz M.
    Int J Cardiol; 2016 Aug 15; 217():7-11. PubMed ID: 27167103
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators.
    Eur Heart J; 2009 Mar 15; 30(5):540-8. PubMed ID: 19136486
    [Abstract] [Full Text] [Related]

  • 29. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
    Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R.
    Am Heart J; 2013 Oct 15; 166(4):654-661.e6. PubMed ID: 24093844
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic effects of a beta adrenergic blocking agent-atenolol in patients with severe mitral stenosis.
    Thongtang V, Srivanasont N, Chaithiraphan S.
    J Med Assoc Thai; 1993 Jan 15; 76(1):9-16. PubMed ID: 8228697
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
    Colin P, Ghaleh B, Hittinger L, Monnet X, Slama M, Giudicelli JF, Berdeaux A.
    Am J Physiol Heart Circ Physiol; 2002 Feb 15; 282(2):H672-9. PubMed ID: 11788417
    [Abstract] [Full Text] [Related]

  • 32. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M.
    Am J Hypertens; 2006 Sep 15; 19(9):927-36. PubMed ID: 16942935
    [Abstract] [Full Text] [Related]

  • 33. Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything.
    Feldman AM.
    J Cardiovasc Pharmacol; 2015 Jun 15; 65(6):549-51. PubMed ID: 25714600
    [No Abstract] [Full Text] [Related]

  • 34. Reliability and efficacy of metoprolol and diltiazem in patients having mild to moderate mitral stenosis with sinus rhythm.
    Alan S, Ulgen MS, Ozdemir K, Keles T, Toprak N.
    Angiology; 2002 Jun 15; 53(5):575-81. PubMed ID: 12365866
    [Abstract] [Full Text] [Related]

  • 35. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers.
    Bedet A, Voiriot G, Ternacle J, Marcos E, Adnot S, Derumeaux G, Mekontso Dessap A.
    Anesthesiology; 2020 Feb 15; 132(2):321-329. PubMed ID: 31939847
    [Abstract] [Full Text] [Related]

  • 36. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb 15; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the relationship between functional capacity and right ventricular diastolic function in patients with isolated mitral stenosis and sinus rhythm: a tissue Doppler study.
    Saricam E, Ozbakir C, Yildirim N, Tufekcioglu O, Ocal A, Bascil S, Bozboga S, Sabah Prof I.
    Echocardiography; 2007 Feb 15; 24(2):134-9. PubMed ID: 17313544
    [Abstract] [Full Text] [Related]

  • 38. Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
    Monnet X, Colin P, Ghaleh B, Hittinger L, Giudicelli JF, Berdeaux A.
    Eur Heart J; 2004 Apr 15; 25(7):579-86. PubMed ID: 15120055
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
    Borer JS, Böhm M, Ford I, Robertson M, Komajda M, Tavazzi L, Swedberg K, SHIFT Investigators.
    Am J Cardiol; 2014 Feb 01; 113(3):497-503. PubMed ID: 24332674
    [Abstract] [Full Text] [Related]

  • 40. Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
    Riesen SC, Schober KE, Cervenec RM, Bonagura JD.
    J Vet Cardiol; 2012 Feb 01; 14(2):323-32. PubMed ID: 22578840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.